ARTICLE | Company News

Apitope, KWS Biotest Ltd., Quintiles, GlaxoSmithKline autoimmune news

January 20, 2014 8:00 AM UTC

A consortium led by Apitope will receive funding of up to €6 million ($8.2 million) from the EU's Framework Programme 7 (FP7) to support a Phase I trial of Apitope's vaccine to treat Graves' disease. ...